The strangest thing about the pharmacy counter

You hand over a slip of paper, or these days a code already waiting in the system, and a few minutes later someone tells you a number. Twelve dollars. Or sixty. Or a hundred and forty. You pay it, or you don't. What you almost never do is ask whether the number is right — not whether it's affordable, but whether it reflects what the medication actually costs.

This is not a failure of nerve. It's a failure of information. And once you understand the shape of the problem, the fix turns out to be smaller than you'd think.

Why one number always sounds like the truth

In 1974, the psychologists Amos Tversky and Daniel Kahneman described a quirk of human judgment they called anchoring. When people are asked to estimate an unknown quantity, the first number they encounter pulls their guess toward it — even when that number is arbitrary, even when they know it's arbitrary. The anchor sets the frame, and everything after is judged as a distance from it.

The pharmacy counter is a near-perfect anchoring machine. You arrive with no independent sense of what a month of a common generic should cost. The first and only number you hear becomes the reference point. There is nothing beside it to make it look high or low. A single price, presented with the quiet authority of a register and a white coat, simply reads as the price.

The trouble is that for most prescriptions there is no single price. The same generic drug, filled the same day, can carry strikingly different cash prices at two pharmacies a few blocks apart — a fact pharmacists themselves will confirm if you ask. The number you're quoted is one point in a wide scatter. But anchoring hides the scatter. You can't feel the width of a range you've only ever seen one value from.

The market for lemons, at the prescription window

There's a deeper economic name for what's happening here. In 1970, the economist George Akerlof published a paper that later won a Nobel Prize, describing what goes wrong when one side of a transaction knows far more than the other. His example was used cars — a buyer can't tell a sound car from a "lemon," so the whole market distorts around that ignorance. Economists call the condition information asymmetry.

Filling a prescription is one of the most lopsided everyday transactions most of us ever make. The pharmacy knows its acquisition cost, its markup, the contracted rates flowing through pharmacy benefit managers, and the cash price it's set. You know none of it. You can't comparison-shop in the moment, because the price isn't posted on a shelf — you typically learn it only after the pharmacist has already pulled and counted your pills. By the time you hear the number, the transaction has its own momentum, and turning around feels both rude and pointless.

When one party holds nearly all the information, the price stops being a negotiation and becomes an announcement. That's not a story about villains. It's the predictable result of a market built so that the buyer arrives blind.

You were, until recently, not allowed to be told

If you suspect the system was tilted on purpose, history offers some support. For years, many contracts between pharmacies and benefit managers contained what became known as gag clauses — provisions that barred pharmacists from volunteering that a drug would be cheaper if you simply paid cash instead of running it through your insurance. The pharmacist might know you were about to overpay and be contractually forbidden from saying so unless you asked the exact right question.

This was common enough that Congress acted. In 2018, the Patient Right to Know Drug Prices Act and a companion law for Medicare made those gag clauses unenforceable. Pharmacists can now tell you when cash beats your copay. But the laws removed a muzzle; they didn't hand you a reference price. The burden of knowing what a fair number looks like still sits with you. You're allowed to ask now — but only a question you know to ask gets answered.

The cure for a bad anchor is a better one

Here's the useful part. Anchoring is not a weakness you can scold yourself out of; decades of studies show it operates below conscious effort, on experts and novices alike. You can't think your way past a missing reference point. You can only supply one.

The good news is that a genuine reference point exists. Every month, the Centers for Medicare & Medicaid Services surveys retail pharmacies across the country and publishes the National Average Drug Acquisition Cost — NADAC — which is, roughly, what pharmacies themselves actually pay to buy each drug. It's public data, drug by drug, and it gives you something the counter never does: a national, neutral number sitting next to the one you're about to be quoted.

With that second number in hand, the psychology flips. Now the price at the window isn't the price; it's a price, and you can see how far it sits from the underlying cost. A modest markup over acquisition cost is how a pharmacy stays in business, and that's fair. A quote that towers over it is a signal — not necessarily of dishonesty, but of a place where, on this drug, this week, you'd do better calling somewhere else. The point isn't to begrudge the pharmacy its margin. It's to be able to tell the difference between a reasonable margin and a number that only looked reasonable because you had nothing to weigh it against.

What this looks like in practice

So "how do I tell if I'm being overcharged" has a concrete answer, and it isn't haggle harder. It's arrive with a second number. Before you fill — or before your next refill, since prices drift — find the national-average cost for your specific drug and dose. Hold the quote up against it. If the gap is large, that's your cue to phone two or three nearby pharmacies and ask their cash price for the same thing, by name and strength. Prices move, and the pharmacy that was expensive last quarter may be the cheap one now. The single act of having a reference turns a passive announcement back into a choice.

None of this requires distrust of your pharmacist, who is often your best ally and, since 2018, is finally free to point you toward the cheaper path. It just requires that you stop walking in blind.

Where SnapRx fits

That's the whole reason we built SnapRx. Snap a photo of your prescription label and it pulls the fair, national-average cash price for that exact drug from the CMS NADAC data, then shows you real pharmacies nearby to call — so the number you carry to the counter is yours, not theirs. It won't fill your prescription or replace your pharmacist. It just makes sure you're never judging a price with nothing to compare it to. If you'd like to know the typical number before you pay, you can try it at snaprx.lumenlabs.works.